Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| PROGENICS PHARMACEUTICALS INC | 10 000 | déclaré | 13 juin 2012 | tx 19+115 500−60 000 |
| REGENERON PHARMACEUTICALS, INC. | 7 439 | déclaré | 02 janv. 2018 | tx 251+353 069−331 590 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 02 janv. 2018 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 7 439 | 0.00 USD | deriv |
| 29 sept. 2017 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2 000 | 18.61 USD | |
| 29 sept. 2017 | SALE | REGENERON PHARMACEUTICALS, INC. | 2 000 | 450.00 USD | |
| 29 sept. 2017 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2 000 | 0.00 USD | deriv |
| 03 janv. 2017 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 7 830 | 0.00 USD | deriv |
| 12 déc. 2016 | SALE | REGENERON PHARMACEUTICALS, INC. | 600 | 390.67 USD | |
| 12 déc. 2016 | SALE | REGENERON PHARMACEUTICALS, INC. | 200 | 394.33 USD | |
| 12 déc. 2016 | SALE | REGENERON PHARMACEUTICALS, INC. | 400 | 392.41 USD | |
| 12 déc. 2016 | SALE | REGENERON PHARMACEUTICALS, INC. | 600 | 393.64 USD | |
| 12 déc. 2016 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3 000 | 18.61 USD | |
| 12 déc. 2016 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 200 | 391.36 USD | |
| 12 déc. 2016 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3 000 | 0.00 USD | deriv |
| 04 janv. 2016 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 9 212 | 0.00 USD | deriv |
| 17 sept. 2015 | SALE | REGENERON PHARMACEUTICALS, INC. | 5 000 | 550.00 USD | |
| 17 sept. 2015 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 5 000 | 18.61 USD | |
| 17 sept. 2015 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 5 000 | 0.00 USD | deriv |
| 25 mars 2015 | SALE | REGENERON PHARMACEUTICALS, INC. | 300 | 452.45 USD | |
| 25 mars 2015 | SALE | REGENERON PHARMACEUTICALS, INC. | 700 | 456.36 USD | |
| 25 mars 2015 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 536 | 455.48 USD | |
| 25 mars 2015 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 999 | 454.38 USD | |
| 25 mars 2015 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 5 000 | 18.61 USD | |
| 25 mars 2015 | SALE | REGENERON PHARMACEUTICALS, INC. | 200 | 457.21 USD | |
| 25 mars 2015 | SALE | REGENERON PHARMACEUTICALS, INC. | 265 | 453.71 USD | |
| 25 mars 2015 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 5 000 | 0.00 USD | deriv |
| 02 janv. 2015 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 10 838 | 0.00 USD | deriv |